• Home
  • Study Details
Coming Soon

TBCRC-059: ETHAN: A phase II study comparing different Endocrine THerapies for mAle breast caNcer

This research study is looking to see 1) how well your breast cancer responds to preoperative treatment with endocrine therapy and 2) which endocrine therapy regimen is the most effective treatment for male breast cancer. The study includes a 3-week window phase containing endocrine therapy followed by a 4-month treatment phase where participants are treated with one of four endocrine therapy treatment combinations.

Age & Gender

  • 18 years ~ 99 years
  • Male, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study will start enrolling soon.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Yara Abdou
LCCC - Clinical Trials

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Breast)

IRB Number

24-0493

ClinicalTrials.gov

NCT05501704

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research